Rhenman & Partners strengthens investment team – hires additional biopharma PM

Rhenman & Partners hires Camilla Oxhamre Cruse as Portfolio Manager – biotech and pharma. She will have a particular focus on companies within pharmaceutical development. Camilla joins Rhenman & Partners’ investment team of four people, all based in their Stockholm office. Camilla has a master’s degree in biochemistry from Lund University (Lund) and obtained a […]

Rhenman & Partners celebrates 15 years

On 21 May Rhenman & Partners took the opportunity to celebrate 15 successful years by inviting guests to a seminar in Stockholm. The article below is a summary of the day and captures the key messages from each presentation. Click here to read or download the article as a PDF.   Rhenman & Partners celebrates […]

RHE L/S winner of Hedgeweek European Awards 2021: Best Global Equity Hedge Fund

  European institutional investors, high net worth individuals, investment advisors, fund managers, and prime brokers have awarded Rhenman Healthcare Equity L/S the winner of Hedgeweek Awards 2021 in the category ”Best Global Equity Hedge Fund”. Voting took place after a nominating procedure where the specialist newswire Hedgeweek in cooperation with Bloomberg selected the best performing […]

Rhenman & Partners wins four prestigious awards at the Nordic Hedge Awards: Best Nordic Hedge Fund Overall 2017, Best Nordic Equity Hedge Fund 2017, and Best Performance Awards for 1 and 5 Years respectively.

The sector fund Rhenman Healthcare Equity L/S was named as a four-time winner at this year’s Nordic Hedge Awards; best hedge fund of all Nordic hedge funds (of which there are 154), best Nordic equity hedge fund, and best-performing Nordic hedge fund for one and five years respectively. The awards were made in the categories […]

SV